Chalk one up for the Canadians, eh. Bob & Doug McKenzie would be so proud. Researchers from the Montreal Neurological Institute of McGill University and the Ludmer Centre for Neuroinformatics recently published, in NeuroImage, a paper that introduces and validates the concept of the personalized Therapeutic Intervention Fingerprint (pTIF), which predicts the effectiveness of potential interventions for controlling a patient’s disease evolution. Think personalized medicine from a brain perspective. Using pTIF subtypes, drugs can be designed for a patient’s unique gene expression profile and phenotypic brain characteristics, which is a major advancement in personalized medicine. For some cool images go here. Their first focus is on Alzheimer’s disease patients. So, don’t be a hoser, stop watching anti-drug commercials, and enjoy the McKenzie’s 12 Days of Christmas song.